Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes

NCT01481116 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

2454

Enrollment

INDUSTRY

Sponsor class

Stopped Due to potential concerns about liver safety (See Detailed Description)

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: TAK-875
DRUG: TAK-875
DRUG: Glimepiride

Sponsor

Takeda